The present invention is characterised by certain genetic variants being susceptibility variants for prostate cancer. The invention relates to methods of determining increased susceptibility to prostate cancer, as well as methods of determining decreased susceptibility to prostate cancer, using such variants. The invention further relates to kits for determining a susceptibility to prostate cancer.

 
Web www.patentalert.com

< SYSTEMS AND METHODS FOR SIMULATING EFFECTS OF AGE-RELATED COGNITIVE OR PHYSICAL DECLINE

> IRON-REGULATING PROTEIN-2(IRP-2) AS A DIAGNOSTIC FOR NEURODEGENERATIVE DISEASE

> IL-17 homologous polypeptides and therapeutic uses thereof
~ 00582